Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
By focusing on attentive, personalized care and safety, our team of experts can help you achieve your goals
Tirzepatide (Mounjaro) is a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes, offering substantial HbA1c reductions of 1.9% to 2.6%
Work with a prescriber familiar with peptide pharmacology if considering off-label use
Can I Switch From Lexapro to Wegovy Without a Healthcare Providers Guidance
GLP-1 receptors are distributed not only in the pancreas and brain but also in the cardiovascular system, kidneys, and gastrointestinal tract
US$ 23.87
US$ 28.52
US$ 22.47
US$ 29.79
US$ 21.64
US$ 20.22
